Research Paper Volume 15, Issue 17 pp 8744—8769
Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer
Figure 6. Relationship between CLCN4 expression and Immune-Score. (A) BLCA. (B) BRCA. (C) ESCA. (D) GBM. (E) HNSC. (F) KIRC. (G) LAML. (H) LGG. (I) LUSC. (J) OV. (K) PCPG. (L) PRAD. (M) SARC. (N) SKCM. (O) TGCT. (P) THCA. (Q) THYM. (R) UCEC. (S) UCS. (T) UVM.